Discover effective chiropractic rehabilitation strategies to support testosterone health and foster a healthier lifestyle.

Integrative Male Hormone Health: How Chiropractic Care Fits Testosterone Assessment and Collaborative Treatment

I have cared for men across a wide range of ages, activity levels, and injury histories, from weekend athletes and first responders to executives living under sustained stress. A single blood draw that reads “normal” often leaves the real story unfinished. When a man in his mid-forties sits in clinic with a morning total testosterone around 370 ng/dL, reduced vitality, central weight gain, fragmented sleep, slower recovery, low mood, and changes in libido or erectile function, I do not reassure him and move on. I ask, examine, and measure.

In integrative care, we do not chase a number. We look for coherence between symptoms, biomarkers, and the systems that set the hormonal environment. Is the pituitary under-signaling? Are the testes not responding? Is estradiol throttling luteinizing hormone (LH) through negative feedback? Is sex hormone-binding globulin (SHBG) limiting the free fraction? Are metabolic inflammation, pain, sleep debt, or medication exposure suppressing the hypothalamic-pituitary-gonadal (HPG) axis?

This post explains what testosterone does, what happens when comorbidities disrupt it, how we read the laboratory pattern, and where chiropractic care belongs. Chiropractic care does not replace testosterone and does not directly raise testosterone levels. It addresses the mechanical and autonomic side of the problem so that medical care, rehabilitation, and lifestyle change have a body that can actually respond.

Our Collaborative Model in El Paso

I practice at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas. Complex hormone problems are not a single-discipline job.

Maria Guadalupe Cardenas, MD, board-certified in internal medicine (NPI 1164426748; Texas medical license J2933), serves as Medical Director and Collaborative Physician. Some earlier clinic materials listed NPI 1164426749; current provider records identify 1164426748, which we use in publication. With more than four decades of internal medicine experience, she oversees diagnostic standards, medication decisions, advanced testing, and safety monitoring.

I, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, integrate chiropractic care, functional medicine, rehabilitative exercise, nutritional therapeutics, and, when medically indicated, peptide or pharmacologic protocols within that supervised framework. Rehab specialists, nutrition professionals, and case managers help carry out the plan, especially in personal injury care, where pain, sleep loss, deconditioning, and stress physiology converge.

Further clinical writing is available at dralexjimenez.com and on LinkedIn.

What Testosterone Does in the Body

Testosterone is an androgen produced mainly by Leydig cells in the testes under LH stimulation. A smaller amount comes from adrenal precursors. Production starts with cholesterol. The steroidogenic acute regulatory (StAR) protein moves cholesterol into mitochondria, and enzymes including CYP11A1 and CYP17A1 convert it to pregnenolone and androstenedione, then to testosterone. Zinc, magnesium, selenium, vitamin D, and adequate protein support that machinery. They don’t replace a working HPG axis.

Once in circulation, most testosterone is bound to SHBG or albumin. Only a small free fraction enters cells and activates the androgen receptor. Dihydrotestosterone, formed by 5-alpha reductase, is a more potent androgen in selected tissues. Aromatase, concentrated in adipose tissue, endothelium, and brain, converts testosterone to estradiol. Estradiol is not a waste product. In men, it supports bone health, vascular function, sexual function, and mood. The problem is excess relative to testosterone, not the presence of estradiol itself.

At the tissue level, adequate androgen action supports:

• Skeletal muscle protein synthesis, strength, and recovery, which improves glucose disposal.

• Bone mineral density and fracture resistance.

• Libido, erectile physiology, and spermatogenesis, the last of which depends on high intratesticular testosterone driven by LH and follicle-stimulating hormone (FSH).

• Red blood cell production.

• Energy, motivation, and aspects of mood and cognitive stamina.

• Body-composition balance, including resistance to visceral fat gain.

The Endocrine Society recommends testosterone therapy for men with symptoms of deficiency and consistently low, accurately measured morning testosterone, after the cause has been evaluated and benefits and risks have been discussed. It does not recommend treating fatigue, aging, or weight gain based on a single borderline result, and it recommends against routine treatment of all men 65 and older with a low value (Bhasin et al., 2018).

What Happens When Comorbidities Disrupt the Axis

Low testosterone is often a signal, not the original injury. Comorbidities change the signal, the factory, the binding proteins, and the tissues that receive the hormone.

Obesity and insulin resistance. Visceral fat expresses aromatase, so it converts more testosterone to estradiol. Estradiol and inflammatory cytokines suppress gonadotropin-releasing hormone (GnRH) and LH. Insulin resistance and lower sex-steroid action then favor further fat gain and muscle loss. Weight loss, by contrast, raises testosterone and improves cardiometabolic markers in men with obesity-related hypogonadism (Grossmann, 2011). In clinic, I often see this as central adiposity, total testosterone in the 300s, disappointingly low free testosterone, and poor recovery from routine training.

Sleep loss and sleep apnea. Testosterone secretion rises with slow-wave sleep. One week of sleep restriction to 5 hours a night lowered daytime testosterone by about 10% to 15% in healthy young men (Leproult & Van Cauter, 2011). Obstructive sleep apnea fragments those pulses, raises nighttime sympathetic drive, and is a reason to treat the airway before blaming the testes. Untreated severe apnea is also a setting in which testosterone therapy needs particular caution (Bhasin et al., 2018).

Chronic pain, injury, and opioid exposure. Persistent nociception raises sympathetic tone and cortisol. Cortisol and testosterone inhibit each other across the hypothalamic-pituitary-adrenal (HPA) and HPG axes (Kovanur Sampath et al., 2019). Opioids suppress GnRH and are a classic cause of central hypogonadism. In personal injury care, I regularly see men whose labs look “centrally quiet” (low or inappropriately normal LH and FSH with low testosterone) after months of pain, poor sleep, and deconditioning, not because the testes failed.

Inflammation and chronic illness. Systemic inflammation, liver disease, and critical illness suppress GnRH pulsatility and alter SHBG. Low endogenous testosterone is associated with higher all-cause and cardiovascular mortality in community cohorts, with substantial heterogeneity tied to underlying health (Araujo et al., 2011). That association does not prove that increasing the number with a prescription reverses the risk.

Thyroid, prolactin, medications, and toxicant load. Hyperthyroidism raises SHBG and can leave total testosterone looking acceptable while free testosterone is low. Hyperprolactinemia suppresses GnRH. SSRIs, finasteride, antipsychotics, and exogenous androgens each disturb the axis in different ways. Alcohol increases aromatase activity and impairs hepatic clearance. These are reversible contributors until someone treats them as a permanent diagnosis.

Aging. Population studies show a gradual decline with age, but health and lifestyle explain much of that decline (Travison et al., 2007). Aging-related Leydig cell change is real. It is not an excuse to skip the comorbidity workup.

I see the musculoskeletal face of this physiology on examination. Low androgen action overlaps with less muscle, more fat, lower bone density, slower tissue recovery, and joints that tolerate load poorly. Men then move less, pain rises, sleep worsens, and the axis is suppressed further. That loop is the clinical opening for chiropractic care.

Signs of Hormonal Imbalances In Men *THIS IS WHY*- Video

Central Versus Peripheral Hypogonadism

Hypogonadism means insufficient testosterone action at tissue level, not a single low total value.

• Central (secondary): LH and FSH are low or inappropriately normal for a low testosterone. The testes may be capable but under-signaled. Drivers include sleep loss, illness, opioids, hyperprolactinemia, estradiol feedback, caloric deficit, and pituitary disease.

• Peripheral (primary): LH and FSH are elevated, and the testes do not respond. Drivers include testicular injury, varicocele, infection, chemotherapy or radiation, genetic causes, and age-related Leydig cell decline.

Treatment has to match the pattern. A low signal suggests restoring upstream drivers, and in selected men, a selective estrogen receptor modulator (SERM) or human chorionic gonadotropin (hCG) under medical supervision. A high signal with poor testicular response may need hCG, attention to the testicular environment, and, if recovery is not realistic, carefully monitored testosterone therapy. Fertility plans change the choice: exogenous testosterone suppresses intratesticular testosterone and sperm production (Bhasin et al., 2018).

The Laboratory Pattern, Not a Single Number

A symptomatic man with a morning total testosterone near 370 ng/dL needs a panel, repeated on a separate morning because of diurnal variation (Bhasin et al., 2018).

• LH and FSH separate central from peripheral patterns. As a clinical rule of thumb, LH below about 3 IU/L with low testosterone suggests under-signaling; LH above about 8 IU/L with low testosterone suggests the pituitary is driving and the testes are not answering. Assay reference ranges still govern the report.

• Total testosterone is the circulating pool, not tissue action.

• Free testosterone and SHBG show how much is available. A man can have a robust total and a low free fraction if SHBG is high.

• Estradiol, measured with a sensitive assay, reflects aromatization and feedback.

• Prolactin screens for a suppressible central cause.

• Thyroid tests (TSH, free T4, free T3) explain some SHBG shifts.

• Morning cortisol and late-night salivary cortisol when the history suggests HPA disruption.

• Fasting glucose, insulin, HbA1c, and lipids map metabolic load.

• Vitamin D, zinc, magnesium, ferritin, and B12/folate cover cofactors for steroidogenesis.

• hs-CRP, liver enzymes, and kidney function frame inflammation and medication safety.

Four patterns guide the next step:

• Low LH/FSH with low total and free testosterone: central. Look at sleep, pain, opioids, prolactin, estradiol, and illness.

• High LH/FSH with low total and free testosterone: peripheral. Look at testicular history and consider an hCG trial.

• Normal total, low free, high SHBG: functional androgen shortage. Address thyroid excess, liver health, and training nutrition.

• High estradiol with suppressed LH: aromatase-dominant feedback. Reduce visceral fat before reaching for a drug that blocks estrogen.

Clinical Observations From Practice

These patterns recur in our El Paso clinic and are discussed in my educational articles (Hormonal Imbalances in Men and Chiropractic Care; Subcutaneous Testosterone for Hormone Balance).

• A man with total testosterone of 350 to 400 ng/dL, a low-normal free fraction, higher SHBG, central adiposity, and poor sleep often reports fatigue and slow workout recovery. When sleep architecture, visceral fat, protein intake, and pain-limited movement improve, free testosterone often rises before any hormone is prescribed.

• Men in personal injury care, living with psychosocial stress and chronic pain, often show central suppression with higher evening cortisol and broken sleep. Reducing nociception and restoring graded movement is part of endocrine care, not a side errand.

• Men who used transdermal testosterone have often described fluctuating symptoms, water retention, and more estrogenic effects. Carefully dosed subcutaneous or intramuscular testosterone has been more stable in my practice when therapy is actually indicated, consistent with pharmacokinetic comparisons of routes (Figueiredo et al., 2022).

• Zinc, vitamin D, magnesium, and omega-3 repletion, paired with lower alcohol intake, regularly improves energy and inflammatory tone over 8 to 12 weeks. Nutrients support an axis that is being asked to work. They do not override opioids, apnea, or a failed testis.

• When elevated SHBG tracks with thyroid excess or liver strain, correcting those drivers often restores the free fraction without escalating a replacement dose.

• I do not describe an adjustment as a testosterone treatment. Progressive resistance exercise builds muscle. Chiropractic care and rehabilitation help selected patients move comfortably enough to do that exercise (Jimenez, 2026).

How Chiropractic Care Relates to Testosterone Health

The honest mechanism is indirect, and the evidence should be stated at its real strength.

Spinal manipulation produces neurophysiological effects through peripheral, autonomic, and endocrine pathways (Bialosky et al., 2009). A controlled study in healthy men found an immediate drop in salivary cortisol after a thoracic manipulation, without a differential change in testosterone itself (Sampath et al., 2017). A 2024 systematic review update found low-quality evidence that manipulation can shift cortisol and inflammatory markers after treatment, and very low-quality evidence that it does not meaningfully change testosterone (Kovanur Sampath et al., 2024). Short-term biomarker shifts are not a course of hormone therapy.

The evidence supports a different claim, and it’s what I use clinically.

Pain and the HPG axis. Chronic pain is a sustained stressor. It elevates sympathetic output and cortisol and crowds out GnRH. Adjustments, soft-tissue work, and graded loading reduce nociceptive traffic. Less pain means less HPA pressure on the HPG axis, and less need for opioids that directly suppress GnRH.

Movement as the anabolic stimulus. Resistance training increases androgen-receptor content in muscle, improves insulin sensitivity, and lowers the visceral fat that drives aromatase. Men in pain often cannot train. Chiropractic care earns a place in a hormone plan by restoring joint motion, hip and thoracic mechanics, and load tolerance, making training possible and repeatable.

Sleep and autonomic recovery. Night pain and restricted thoracic or cervical motion fragment sleep. Testosterone pulses depend on slow-wave sleep (Leproult & Van Cauter, 2011). Improving breathing mechanics and reducing pain that wakes a patient supports the nocturnal window when the axis actually secretes.

Inflammation and tissue recovery. Low-grade inflammation suppresses GnRH and slows tendon and muscle repair. Manual care isn’t an anti-inflammatory drug, but reducing mechanical irritation and returning to circulation-promoting movement lowers the everyday inflammatory load that keeps men deconditioned.

Posture and respiratory mechanics. Diaphragm and rib motion affect ventilation and vagal tone. Men who cannot expand the chest after a crash or a lifting injury often breathe high and fast, which sustains sympathetic arousal. Thoracic mobility work is endocrine-relevant because it is sleep-relevant and training-relevant.

I tell patients directly: an adjustment will not replace a low morning testosterone of 180 ng/dL from testicular failure. It can remove the mechanical and pain barriers that keep a correctable, central pattern from recovering.

Combined Nonsurgical Care

Hormone health in this clinic is a stack, not a menu of competing therapies.

Chiropractic care restores segmental motion, reduces nociception, and guides safe movements for the week.

Massage therapy addresses myofascial tone, trigger points, and guarding that adjustments alone do not resolve. Lower resting muscle tone makes sleep and training tolerable. It is adjunctive pain care, not a hormone prescription.

Physical therapy supplies the loading. Tendon and muscle need progressive resistance, zone 2 aerobic work, and periodization so cortisol does not outrun recovery. Physical therapy is where androgen receptor density and insulin sensitivity actually change.

Functional wellness covers the metabolic drivers: protein at about 1.6 to 2.2 g/kg of lean mass for active men, omega-3 fats, fiber, reduced alcohol, and repletion of vitamin D, zinc, magnesium, and selenium. It also covers light timing, consistent sleep windows, and apnea screening.

Medical oversight decides whether the pattern needs observation, a fertility-sparing agent such as clomiphene or hCG, or testosterone therapy. Dr. Cardenas anchors that decision. Monitoring includes testosterone, estradiol, hematocrit, lipids, and age-appropriate prostate assessment (Bhasin et al., 2018).

In a typical central pattern after injury, the sequence is sleep and apnea evaluation, opioid taper when medically appropriate, chiropractic and massage care to cut pain, physical therapy to reload muscle, and nutrition to shrink the aromatase reservoir. Medication is added if the axis does not recover, not instead of this work.

Medical Options, Matched to Physiology

Lifestyle correction comes first because it changes the same physiology the drugs target.

• Sleep of roughly 7.5 to 8.5 hours, a stable schedule, and treatment of apnea.

• Resistance training most weeks, zone 2 aerobic base, and mobility work without overreaching.

• Estradiol balanced by fat loss and lower alcohol intake, not driven to zero. Over-suppression harms bone, mood, and sexual function.

• For persistent central suppression, clomiphene can block estrogen negative feedback and raise LH and endogenous testosterone while sparing fertility. hCG mimics LH at the testis and supports intratesticular testosterone. Kisspeptin analogs and growth-hormone secretagogues such as CJC without DAC and ipamorelin are adjuncts under medical supervision, aimed at GnRH tone, sleep, and body composition, not stand-alone cures.

• Testosterone therapy, when indicated, is aimed at mid-normal concentrations with a formulation the patient can use consistently. Injections, including subcutaneous routes for appropriate products, often give steadier levels than gels (Figueiredo et al., 2022; Spratt et al., 2017). Gels remain reasonable when absorption is stable, and transfer risk is controlled. Therapy is deferred in men planning near-term fertility and in men with specified contraindications, including markedly elevated hematocrit, untreated severe apnea, recent cardiovascular events, or unevaluated prostate abnormalities (Bhasin et al., 2018).

A Practical Roadmap

For a symptomatic man with a morning total testosterone near 370 ng/dL:

1. Confirm with a second morning total and free testosterone, plus LH, FSH, SHBG, sensitive estradiol, prolactin, thyroid, and metabolic labs.

2. Name the pattern: central, peripheral, high SHBG, or estradiol-dominant.

3. If central, repair sleep, reduce pain and opioids, reload training through chiropractic care, massage, and physical therapy, and recheck in 8 to 12 weeks before committing to long-term replacement.

4. If peripheral, evaluate testicular causes, consider an hCG trial, and use testosterone therapy if the testes cannot recover, with a fertility plan if needed.

5. Track symptoms, free testosterone, estradiol, hematocrit, and training tolerance. Change one major variable at a time.

Escalate to pituitary imaging or endocrinology when central suppression is severe, prolactin is high, or comorbidities exceed the clinic’s scope. Dr. Cardenas directs those referrals.

Closing

Testosterone health is a system: nocturnal pulses, pituitary signaling, testicular response, a usable free fraction, estradiol in proportion, and a body that can train and sleep. Comorbidities break that system at predictable points. Chiropractic care belongs in the repair because pain, joint mechanics, autonomic load, and the ability to train are part of the axis, not background noise. It does not replace medical diagnosis or testosterone therapy when those are required. Used with massage therapy, physical therapy, functional wellness, and internal-medicine oversight, it gives the rest of the plan a fair chance to work.

Educational material on this site is not a substitute for a relationship with a qualified clinician. Laboratory targets and medication choices belong in a supervised plan.

References

• Araujo, A. B., Dixon, J. M., Suarez, E. A., Murad, M. H., Guey, L. T., & Wittert, G. A. (2011). Endogenous testosterone and mortality in men: A systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism, 96(10), 3007-3019. https://doi.org/10.1210/jc.2011-1137
• Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1715-1744. https://doi.org/10.1210/jc.2018-00229
• Bialosky, J. E., Bishop, M. D., Price, D. D., Robinson, M. E., & George, S. Z. (2009). The mechanisms of manual therapy in the treatment of musculoskeletal pain: A comprehensive model. Manual Therapy, 14(5), 531-538. https://doi.org/10.1016/j.math.2008.09.001
• Figueiredo, M. G., Gagliano-Juca, T., & Basaria, S. (2022). Testosterone therapy with subcutaneous injections: A safe, practical, and reasonable option. The Journal of Clinical Endocrinology & Metabolism, 107(3), 614-626. https://doi.org/10.1210/clinem/dgab772
• Grossmann, M. (2011). Low testosterone in men with type 2 diabetes: Significance and treatment. The Journal of Clinical Endocrinology & Metabolism, 96(8), 2341-2353. https://doi.org/10.1210/jc.2011-0118
• Jimenez, A. (2022). Hormonal imbalances in men and chiropractic care. DrAlexJimenez.com.
• Jimenez, A. (2026). Subcutaneous testosterone for hormone balance therapy guide. DrAlexJimenez.com.
• Kovanur Sampath, K., Botnmark, E., Mani, R., Cotter, J. D., Katare, R., Munasinghe, P. E., & Tumilty, S. (2017). Neuroendocrine response following a thoracic spinal manipulation in healthy men. Journal of Orthopedic & Sports Physical Therapy, 47(9), 617-627. https://doi.org/10.2519/jospt.2017.7348
• Kovanur Sampath, K., Mani, R., Cotter, J., Gisselman, A. S., & Tumilty, S. (2019). Stress axis and osteopathy: A dual hormone approach. International Journal of Osteopathic Medicine, 33-34, 24-30. https://doi.org/10.1016/j.ijosm.2019.08.002
• Kovanur Sampath, K., Tumilty, S., Wooten, L., Belcher, S., Farrell, G., & Gisselman, A. S. (2024). Changes in biochemical markers following a spinal manipulation: A systematic review update. Journal of Manual & Manipulative Therapy, 32(1), 28-50. https://doi.org/10.1080/10669817.2023.2252187
• Leproult, R., & Van Cauter, E. (2011). Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA, 305(21), 2173-2174. https://doi.org/10.1001/jama.2011.710
• Spratt, D. I., Stewart, I. I., Savage, C., Craig, W., Spack, N. P., Chandler, D. W., Spratt, L. V., Eimicke, T., & Olshan, J. S. (2017). Subcutaneous injection of testosterone is an effective and preferred alternative to intramuscular injection: Demonstration in female-to-male transgender patients. The Journal of Clinical Endocrinology & Metabolism, 102(7), 2349-2355. https://doi.org/10.1210/jc.2017-00359
• Travison, T. G., Araujo, A. B., Kupelian, V., O’Donnell, A. B., & McKinlay, J. B. (2007). The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. The Journal of Clinical Endocrinology & Metabolism, 92(2), 549-555. https://doi.org/10.1210/jc.2006-1859

SEO tags: testosterone optimization, male hypogonadism, central hypogonadism, peripheral hypogonadism, luteinizing hormone, follicle-stimulating hormone, free testosterone, sex hormone-binding globulin, estradiol management, aromatase, kisspeptin, CJC no DAC, Ipamorelin, hCG, clomiphene citrate, testosterone replacement therapy, transdermal testosterone, injectable testosterone, sleep apnea and hormones, integrative chiropractic care, autonomic nervous system, functional medicine, personal injury care, rehabilitation, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, El Paso Texas clinic, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, evidence-based hormone health, men’s health, endocrine resilience, metabolic health, longevity